Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine
Published Online: 2002-02-01
Journal: Nature Medicine•Publisher: Springer Science and Business Media LLC
Authors: Dennis Mitchell•Dorothee Chabas•Joe E. Springer•Lawrence Steinman•Marcela V. Karpuj•Mark W. Becher•Rosetta Pedotti•Sawsan Youssef
